John Martin Corkery

University of Hertfordshire

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (6)

Suzanne Fergus

University of Hertfordshire

UNITED KINGDOM

View details

Mauro Pettorruso

Medical Doctor, Specialist in Psychiatry

ITALY

View details

Norbert Scherbaum

Professor for Clinical Addiction Research

University of Duisburg-Essen Faculty of Medizin

GERMANY

View details

Giovanni Martinotti

ITALY

View details

Fabrizio Schifano

University of Hertfordshire

UNITED KINGDOM

View details

Rachel Vickers-Smith

Assistant Professor

University of Kentucky

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

John Martin Corkery

Research Interests

Explore related searches

Contact this professor

Articles (20)

Drugs Used in “Chemsex”/Sexualized Drug Behaviour—Overview of the Related Clinical Psychopharmacological Issues

Focus on Cognitive Enhancement: A Narrative Overview of Nootropics and “Smart Drug” Use and Misuse

Adverse Drug Reactions Associated with Concomitant Use of Calcium Channel Blockers and Cocaine: An Analysis of FDA Adverse Events Reporting System Data

An Update on Deaths in the United Kingdom from ‘Poppers’ (Alkyl Nitrites), with a Particular Focus on ‘Swallowing’ Fatalities

Deaths following illicit ketamine use in England, Wales and Northern Ireland 1999–2024: An update report to inform the reclassification debate

Deaths related to the use of diarylethylamines, with a focus on the United Kingdom: A systematic review and case series report

Xylazine as an emerging new psychoactive substance; focuses on both 5‐HT 7 and κ‐opioid receptors' molecular interactions and isosteric replacement

Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders

Piperazine Abuse and Psychosis: A Systematic Review of the Literature

Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset

Correction to: Benefits and Harms of ‘Smart Drugs’ (Nootropics) in Healthy Individuals

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS)

A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases

First death involving 4-Fluoroethylphenidate (4F-EPH): case-report, user experiences, and review of the related literature

Alprazolam-related deaths in Scotland, 2004-2020

Designer Benzodiazepines’ Activity on Opioid Receptors: A Docking Study

Alprazolam-related deaths in Scotland, 2004–2020

Contribution of drugs to drownings in Scotland, 1996-2020

In silico studies on recreational drugs: 3D quantitative structure activity relationship prediction of classified and de novo designer benzodiazepines

Collaborators (6)

Suzanne Fergus

Mauro Pettorruso

Norbert Scherbaum

Giovanni Martinotti

Fabrizio Schifano

Rachel Vickers-Smith

Make your next move.